The global artificial intelligence (AI) in healthcare market revenue is expected to attain around USD 187.95 billion by 2030 with a CAGR of 37% between 2022 and 2030.
The global semiconductor chip ecosystem industry is growing at faster pace due to rising demand for connected devices, rising semiconductor sales, and rising R&D expenditures.
The global power generation industry will reach at a CAGR of 8.04% through 2032 due to significant rise in energy efficiency as a result of technology advancements and behavioral changes.
The dermocosmetic skin care products industry is expected to grow at a CAGR of 9.71% and will expand as a result of increased knowledge about skin and hair issues.
The cancer biological therapy industry is predicted to reach at a CAGR of 8.02% from 2023 to 2032 due to increased the demand for cancer biological treatment.
The global logistics industry revenue will attain around USD 18.23 trillion by 2032 from USD 10.68 trillion in 2022 and is poised to grow at a CAGR of 5.48%.
The global non-opioid pain treatment industry revenue will touch around USD 79.7 billion by 2032 from USD 42.3 billion in 2022 and is growing at a CAGR of 6.54%
The global immunohistochemistry industry revenue will gain around USD 4.5 billion by 2032 from USD 2.4 billion in 2022 and is growing at a remarkable CAGR of 6.49%.
The global laboratory filtration industry revenue will increase to USD 8.1 billion by 2032 from USD 3.9 billion in 2022 and is growing at a remarkable CAGR of 7.58%.
The global green steel industry revenue will attain around USD 6,24,414.85 million by 2032 from USD 196.84 million in 2022 and is poised to grow at a CAGR of 123.94%.
The global B2B sports nutrition industry size was appraised at USD 3.78 billion in 2022 and is estimated to hit USD 7.68 billion by 2032 with a CAGR of 7.35%.
The global automotive disruption radar industry is surging, with an overall revenue growth expectation of hundreds of millions dollars from 2023 to 2032.
The global anti-biofilm wound dressing market size is expected to reach around USD 1,647.45 million by 2032 from USD 745.8 million in 2022, growing at a CAGR of 8.25%.
The antibody drug conjugates industry size reached USD 9.04 billion in 2022 and is predicted to reach around USD 25.46 billion by 2032 with a CAGR of 10.91%.